Please provide your email address to receive an email when new articles are posted on . Published findings indicated that while patients 77 years or older had lower likelihoods of arteriovenous ...

Please provide your email address to receive an email when new articles are posted on . For older patients who initiated hemodialysis without permanent access, those with arteriovenous fistula ...

More than a third of patients required interventions to foster AVF maturation. Intervention is commonly required to foster maturation of arteriovenous fistulas (AVFs), maintain patency, and treat ...

An investigational product called Acellular Tissue Engineered Vessel demonstrated superior hemodialysis vascular access outcomes compared with AVFs in a phase 3 trial. A bioengineered human tissue ...

The successful creation and use of arteriovenous fistulas (AVFs) for vascular access for dialysis patients varies considerably between countries, despite national guidelines that uniformly recommend ...

This requires durable access to a blood vessel site where the dialysis machine can remove and return blood. Such access is created when a surgeon attaches a vein to an artery in the patient. The ...

Arteriovenous fistulae (AVF) are the access of first choice, with AVF use greatly differing across countries. However, AVFs are not suitable for all patients. Thus, to maximize patient outcomes and ...

Timmy Lee, MD, MSPH, is Associate Professor of Medicine in the Division of Nephrology and Staff Nephrologist at the Birmingham Veterans Affairs Medical Center. He is the Associate Director of ...

BIRMINGHAM, Ala. – More than 600,000 people in the United States have end-stage kidney disease, and about 450,000 are kept alive through chronic hemodialysis to remove waste products from their blood.